Skip to main content
Premium Trial:

Request an Annual Quote

BGI, Leiden to Use FlexGen Target Enrichment in Dutch Genome Project

Premium

FlexGen of the Netherlands said last week that China's BGI and Leiden University Medical Center will use its target enrichment technology to validate variants for the Genome of the Netherlands, or GoNL, project.

The researchers will use the platform to validate a set of variants found in trio samples from the GoNL project. Launched in 2010, the project aims to sequence the genomes of about 250 Dutch parent-child trios. The sequencing is performed at BGI's Hong Kong facility.

FlexGen, located in the Leiden Bio Science Park, was founded in 2004 as a spinoff from Leiden University Medical Center and Dutch Space. The company offers FleXelect custom target enrichment kits.

The Scan

Call for a Different Tack

Experts weigh the value of recent experiments testing genetically modified pig kidneys using brain-dead individuals, according to Nature News.

Wastewater Warning

The New York Times reports that wastewater surveillance in some parts of the US point to a possible surge.

Can't Get in the Program

Due to the Northern Ireland protocol dispute, the European Union is preventing UK researchers from joining the Horizon Europe research program, the Times of London reports.

Science Paper on Spatial-Controlled Genome Editing

In Science this week: approach to enable a CRISPR-Cas13a-based system to be used as a cancer therapy.